Cargando…
Association between cumulative exposure periods of flupentixol or any antipsychotics and risk of lung cancer
BACKGROUND: Preclinical evidence suggests that certain antipsychotic medications may inhibit the development of lung cancer. This study aims to investigate the association between incident lung cancer and different cumulative exposure periods of flupentixol or any antipsychotics. METHODS: Using elec...
Autores principales: | Chai, Yi, Chu, Rachel Yui Ki, Hu, Yuqi, Lam, Ivan Chun Hang, Cheng, Franco Wing Tak, Luo, Hao, Wong, Martin Chi Sang, Chan, Sandra Sau Man, Chan, Esther Wai Yin, Wong, Ian Chi Kei, Lai, Francisco Tsz Tsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522572/ https://www.ncbi.nlm.nih.gov/pubmed/37752185 http://dx.doi.org/10.1038/s43856-023-00364-z |
Ejemplares similares
-
Flupentixol tartrate
por: Yamuna, Thammarse S., et al.
Publicado: (2014) -
Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals
por: Leung, Janice Ching Nam, et al.
Publicado: (2022) -
Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals—CORRIGENDUM
por: Leung, Janice Ching Nam, et al.
Publicado: (2022) -
The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer
por: Dong, Chao, et al.
Publicado: (2019) -
Melitracen and flupentixol (deanxit) use disorder in Lebanon
por: El Zahran, Tharwat, et al.
Publicado: (2023)